The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

• Status: Recruiting
• Trial end date: 2023-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

This randomized controlled study aims to investigate the efficiency of medical treatment modalities in endometriosis patients. The study protocol involves two arms. (Dienogest Group and Noretindrone Acetate Group). The patients diagnosed with endometriosis are randomized depending on their protocol ids. The Dienogest group is prescribed 5 mg dienogest per day and neta group is prescribed 5 mg neta per day. The pain scores will be analyzed six months and twelve months after treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Uludag University
• Treatments: Dienogest; Norethindrone; Norethindrone Acetate

Criteria

Inclusion Criteria:

• 18 - 40 years aged women diagnosed with endometriosis

Exclusion Criteria:

• malignancy

• need for surgery

• pregnancy desire